相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis
Bruno R. da Costa et al.
LANCET (2016)
The Changing Epidemiology of Myocardial Infarction in Olmsted County, Minnesota, 1995-2012
Yariv Gerber et al.
AMERICAN JOURNAL OF MEDICINE (2015)
Comparative Effectiveness of Pharmacologic Interventions for Knee Osteoarthritis A Systematic Review and Network Meta-analysis
Raveendhara R. Bannuru et al.
ANNALS OF INTERNAL MEDICINE (2015)
Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations
Irene R. Degano et al.
HEART (2015)
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
N. Bhala et al.
LANCET (2013)
被撤回的出版物: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet (Retracted article. See vol. 378, pg. 2441, 2018)
Ramon Estruch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies
Cristina Varas-Lorenzo et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)
Thomas M. MacDonald et al.
BMJ OPEN (2013)
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial
Francis K. L. Chan et al.
LANCET (2010)
Long-term follow-up of the West of Scotland Coronary Prevention Study
Ian Ford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Risk of cardiovascular events in patients receiving celecoxib: A meta-analysis of randomized clinical trials
William B. White et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
Patricia M. Kearney et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I study
G Singh et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports
RA Moore et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial
ME Farkouh et al.
LANCET (2004)
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial
TJ Schnitzer et al.
LANCET (2004)
Risk of cardiovascular events associated with selective COX-2 inhibitors
D Mukherjee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
